Akoya Biosciences Inc. (AKYA)
Akoya Biosciences Statistics
Share Statistics
Akoya Biosciences has 49.57M shares outstanding. The number of shares has increased by 0.87% in one year.
| Shares Outstanding | 49.57M |
| Shares Change (YoY) | 0.87% |
| Shares Change (QoQ) | 0.51% |
| Owned by Institutions (%) | 24.51% |
| Shares Floating | 20.79M |
| Failed to Deliver (FTD) Shares | 578 |
| FTD / Avg. Volume | 0.21% |
Short Selling Information
The latest short interest is 2.32M, so 4.66% of the outstanding shares have been sold short.
| Short Interest | 2.32M |
| Short % of Shares Out | 4.66% |
| Short % of Float | 7.66% |
| Short Ratio (days to cover) | 12.41 |
Valuation Ratios
The PE ratio is -2.04 and the forward PE ratio is -2.46. Akoya Biosciences's PEG ratio is 0.09.
| PE Ratio | -2.04 |
| Forward PE | -2.46 |
| PS Ratio | 1.39 |
| Forward PS | 0.5 |
| PB Ratio | 14.9 |
| P/FCF Ratio | -2.43 |
| PEG Ratio | 0.09 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Akoya Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 1.05.
| Current Ratio | 2.61 |
| Quick Ratio | 1.78 |
| Debt / Equity | 1.05 |
| Debt / EBITDA | -0.21 |
| Debt / FCF | -0.17 |
| Interest Coverage | -4.48 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $398.4K |
| Profits Per Employee | $-270.07K |
| Employee Count | 205 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.39 |
Taxes
| Income Tax | 146K |
| Effective Tax Rate | -0.26% |
Stock Price Statistics
The stock price has increased by -65.53% in the last 52 weeks. The beta is 1.33, so Akoya Biosciences's price volatility has been higher than the market average.
| Beta | 1.33 |
| 52-Week Price Change | -65.53% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 2.33 |
| Relative Strength Index (RSI) | 47.99 |
| Average Volume (20 Days) | 278.32K |
Income Statement
In the last 12 months, Akoya Biosciences had revenue of 81.67M and earned -55.37M in profits. Earnings per share was -1.12.
| Revenue | 81.67M |
| Gross Profit | 47.88M |
| Operating Income | -46.73M |
| Net Income | -55.37M |
| EBITDA | -37.14M |
| EBIT | -44.79M |
| Earnings Per Share (EPS) | -1.12 |
Balance Sheet
The company has 11.78M in cash and 7.96M in debt, giving a net cash position of 3.81M.
| Cash & Cash Equivalents | 11.78M |
| Total Debt | 7.96M |
| Net Cash | 3.81M |
| Retained Earnings | -285.44M |
| Total Assets | 125M |
| Working Capital | 47.29M |
Cash Flow
In the last 12 months, operating cash flow was -44.1M and capital expenditures -2.46M, giving a free cash flow of -46.56M.
| Operating Cash Flow | -44.1M |
| Capital Expenditures | -2.46M |
| Free Cash Flow | -46.56M |
| FCF Per Share | -0.94 |
Margins
Gross margin is 58.62%, with operating and profit margins of -57.22% and -67.79%.
| Gross Margin | 58.62% |
| Operating Margin | -57.22% |
| Pretax Margin | -67.61% |
| Profit Margin | -67.79% |
| EBITDA Margin | -45.47% |
| EBIT Margin | -57.22% |
| FCF Margin | -57.01% |
Dividends & Yields
AKYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for AKYA is $3, which is 129% higher than the current price. The consensus rating is "Hold".
| Price Target | $3 |
| Price Target Difference | 129% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 0.25 |
| Piotroski F-Score | 4 |